Zinecard

Active Ingredient(s): Dexrazoxane
FDA Approved: * May 26, 1995
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zinecard Overview

Dexrazoxane hydrochloride (Zinecard by Pfizer in USA and Canada; Cardioxane by Clinigen Group for EU and other countries) is a cardioprotective agent. It was discovered by Kurt Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended for intravenous administration. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs su...

Read more Zinecard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dexrazoxane

Recent Zinecard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexrazoxane
  • Injection: 250mg, 250mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zinecard: (2 results)

Sorted by National Drug Code
  • 0013-8717 Zinecard 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Pharmacia and Upjohn Company
  • 0013-8727 Zinecard 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Pharmacia and Upjohn Company

Other drugs which contain Dexrazoxane or a similar ingredient: (2 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 20 November 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.